Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma

Jiao Xue; Yining Zhu; Shuting Bai; Chunting He; Guangsheng Du; Yuandong Zhang; Yao Zhong; Wenfei Chen; Hairui Wang; Xun Sun

doi:10.1016/j.apsb.2021.11.020

Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma

doi: 10.1016/j.apsb.2021.11.020

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China

基金项目:

We acknowledge the financial support of the National Natural Science Foundation of China (Nos. 81925036 &

81872814), the Science &

Technology Major Project of Sichuan Province (No. 2018SZDZX0018, China), the Key Research and Development Program of Science and Technology Department of Sichuan Province (No. 2020YFS0570, China), 111 project (No. b18035, China) and the Fundamental Research Funds for the Central Universities (China).

详细信息

通讯作者:
Xun Sun,E-mail:sunxun@scu.edu.cn

中图分类号: https://www.sciencedirect.com/science/article/pii/S2211383521004585/pdf?md5=47c3621552fa69901463a4ae19ea62d3&pid=1-s2.0-S2211383521004585-main.pdf
计量
- 文章访问数: 52
- HTML全文浏览量: 34
- PDF下载量: 0
- 被引次数: 0
出版历程
- 收稿日期: 2021-10-15
- 修回日期: 2021-11-09
- 录用日期: 2021-11-20
- 网络出版日期: 2023-03-17

Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China

Funds:

We acknowledge the financial support of the National Natural Science Foundation of China (Nos. 81925036 &

81872814), the Science &

摘要

摘要: Photothermal therapy has been intensively investigated for treating cancer in recent years. However, the long-term therapeutic outcome remains unsatisfying due to the frequently occurred metastasis and recurrence. To address this challenge, immunotherapy has been combined with photothermal therapy to activate anti-tumor immunity and relieve the immunosuppressive microenvironment within tumor sites. Here, we engineered silica-based core-shell nanoparticles (JQ-1@PSNs-R), in which silica cores were coated with the photothermal agent polydopamine, and a bromodomain-containing protein 4 (BRD4) inhibitor JQ-1 was loaded in the polydopamine layer to combine photothermal and immune therapy for tumor elimination. Importantly, to improve the therapeutic effect, we increased the surface roughness of the nanoparticles by hydrofluoric acid (HF) etching during the fabrication process, and found that the internalization of JQ-1@PSNs-R was significantly improved, leading to a strengthened photothermal killing effect as well as the increased intracellular delivery of JQ-1. In the animal studies, the multifunctional nanoparticles with rough surfaces effectively eradicated melanoma via photothermal therapy, successfully activated tumor-specific immune responses against residual tumor cells, and further prevented tumor metastasis and recurrence. Our results indicated that JQ-1@PSNs-R could serve as an innovative and effective strategy for combined cancer therapy.
- Photothermal therapy /
- Immunotherapy /
- Rough surface /
- Polydopamine-coated silica nanoparticles /
- JQ-1 /
- Melanoma
Abstract: Photothermal therapy has been intensively investigated for treating cancer in recent years. However, the long-term therapeutic outcome remains unsatisfying due to the frequently occurred metastasis and recurrence. To address this challenge, immunotherapy has been combined with photothermal therapy to activate anti-tumor immunity and relieve the immunosuppressive microenvironment within tumor sites. Here, we engineered silica-based core-shell nanoparticles (JQ-1@PSNs-R), in which silica cores were coated with the photothermal agent polydopamine, and a bromodomain-containing protein 4 (BRD4) inhibitor JQ-1 was loaded in the polydopamine layer to combine photothermal and immune therapy for tumor elimination. Importantly, to improve the therapeutic effect, we increased the surface roughness of the nanoparticles by hydrofluoric acid (HF) etching during the fabrication process, and found that the internalization of JQ-1@PSNs-R was significantly improved, leading to a strengthened photothermal killing effect as well as the increased intracellular delivery of JQ-1. In the animal studies, the multifunctional nanoparticles with rough surfaces effectively eradicated melanoma via photothermal therapy, successfully activated tumor-specific immune responses against residual tumor cells, and further prevented tumor metastasis and recurrence. Our results indicated that JQ-1@PSNs-R could serve as an innovative and effective strategy for combined cancer therapy.
- Photothermal therapy /
- Immunotherapy /
- Rough surface /
- Polydopamine-coated silica nanoparticles /
- JQ-1 /
- Melanoma

HTML全文

参考文献(57)

[1]	Na IK, Buckland M, Agostini C, Edgar JDM, Friman V, Michallet M, et al. Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies. Eur J Haematol 2019; 102:447-456
[2]	Beik J, Abed Z, Ghoreishi FS, Hosseini-Nami S, Mehrzadi S, Shakeri-Zadeh A, et al. Nanotechnology in hyperthermia cancer therapy:from fundamental principles to advanced applications. J Control Release 2016; 235:205-221
[3]	Zhu YN, Xue J, Chen WF, Bai ST, Zheng T, He CT, et al. Albumin-biomineralized nanoparticles to synergize phototherapy and immunotherapy against melanoma. J Control Release 2020; 322:300-311
[4]	Fidele NB, Zheng YY, Zhao YF, Wu TF, Liu JY, Sun YF, et al. Recurrence of odontogenic keratocysts and possible prognostic factors:review of 455 patients. Med Oral Patol Oral Cir Bucal 2019; 24:e491-e501
[5]	Liu Y, Crawford BM, Vo-Dinh T. Gold nanoparticles-mediated photothermal therapy and immunotherapy. Immunotherapy 2018; 10:1175-1188
[6]	Liang X, Ye XY, Wang C, Xing CY, Miao QW, Xie ZJ, et al. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation. J Control Release 2019; 296:150-161
[7]	Ye X, Liang X, Chen Q, Miao QW, Chen XL, Zhang XD, et al. Surgical tumor-derived personalized photothermal vaccine formulation for cancer immunotherapy. ACS Nano 2019; 13:2956-2968
[8]	Zhang F, Lu GH, Wen XL, Li F, Ji XY, Li QQ, et al. Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal/immunotherapy. J Control Release 2020; 326:131-139
[9]	Li QQ, Shi ZQ, Zhang F, Zeng WW, Zhu DW, Mei L. Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle. Acta Pharm Sin B 2021. Available from:https://doi.org/10.1016/j.apsb.2021.05.031
[10]	Chen WF, Qin M, Chen XY, Wang Q, Zhang ZR, Sun X. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al₂O₃ nanoparticles. Theranostics 2018; 8:2229-2241
[11]	Dreyer DR, Miller DJ, Freeman BD, Paul DR, Bielawski CW. Elucidating the structure of poly(dopamine). Langmuir 2012; 28:6428-6435
[12]	Lee H, Dellatore SM, Miller WM, Messersmith PB. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007; 318:426-430
[13]	Muller M, Kessler B. Deposition from dopamine solutions at Ge substrates:an in situ ATR-FTIR study. Langmuir 2011; 27:12499-12505
[14]	Chen WF, Wang Y, Qin M, Zhang XD, Zhang ZR, Sun X, et al. Bacteria-driven hypoxia targeting for combined biotherapy and photothermal therapy. ACS Nano 2018; 12:5995-6005
[15]	Burzio LA, Waite JH. Cross-linking in adhesive quinoproteins:studies with model decapeptides. Biochemistry 2000; 39:11147-11153
[16]	Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009; 61:428-437
[17]	Saw WS, Ujihara M, Chong WY, Voon SH, Imae T, Kiew LV, et al. Size-dependent effect of cystine/citric acid-capped confeito-like gold nanoparticles on cellular uptake and photothermal cancer therapy. Colloids Surf B 2018; 161:365-374
[18]	Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 2008; 105:11613-11618
[19]	Kolhar P, Anselmo AC, Gupta V, Pant K, Prabhakarpandian B, Ruoslahti E, et al. Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci U S A 2013; 110:10753-10758
[20]	Salatin S, Maleki Dizaj S, Yari Khosroushahi A. Effect of the surface modification, size, and shape on cellular uptake of nanoparticles. Cell Biol Int 2015; 39:881-890
[21]	Huhn D, Kantner K, Geidel C, Brandholt S, De Cock I, Soenen SJ, et al. Polymer-coated nanoparticles interacting with proteins and cells:focusing on the sign of the net charge. ACS Nano 2013; 7:3253-3263
[22]	Mohanty RP, Liu X, Ghosh D. Electrostatic driven transport enhances penetration of positively charged peptide surfaces through tumor extracellular matrix. Acta Biomater 2020; 113:240-251
[23]	Yoo HS, Lee JE, Chung H, Kwon IC, Jeong SY. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. J Control Release 2005; 103:235-243
[24]	Shan W, Zhu X, Liu M, Li L, Zhong JJ, Sun W, et al. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. ACS Nano 2015; 9:2345-2356
[25]	Wang S, Guo H, Li YF, Li XJ. Penetration of nanoparticles across a lipid bilayer:effects of particle stiffness and surface hydrophobicity. Nanoscale 2019; 11:4025-4034
[26]	Guo P, Liu DX, Subramanyam K, Wang BR, Yang J, Huang J, et al. Nanoparticle elasticity directs tumor uptake. Nat Commun 2018; 9:130
[27]	Hou Y, Yu LX, Xie WY, Camacho LC, Zhang M, Chu ZQ, et al. Surface roughness and substrate stiffness synergize to drive cellular mechanoresponse. Nano Lett 2020; 20:748-757
[28]	Rowshanravan B, Halliday N, Sansom DM. CTLA-4:a moving target in immunotherapy. Blood 2018; 131:58-67
[29]	Boutros C, Tarhini A, Routier E, Lambotte O, Ladurie FL, Carbonnel F, et al. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination. Nat Rev Clin Oncol 2016; 13:473-486
[30]	Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim SW, Carcereny Costa E, et al. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. N Engl J Med 2019; 381:2020-2031
[31]	Gao X, McDermott DF. Ipilimumab in combination with nivolumab for the treatment of renal cell carcinoma. Expert Opin Biol Ther 2018; 18:947-957
[32]	Adeegbe DO, Liu Y, Lizotte PH, Kamihara Y, Aref AR, Almonte C, et al. Synergistic immunostimulatory effects and therapeutic benefit of combined histone deacetylase and bromodomain inhibition in non-small cell lung cancer. Cancer Discov 2017; 7:852-867
[33]	Zhu H, Bengsch F, Svoronos N, Rutkowski MR, Bitler BG, Allegrezza MJ, et al. BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression. Cell Rep 2016; 16:2829-2837
[34]	Zhou FQ, Gao J, Xu ZA, Li TL, Gao A, Sun F, et al. Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer. Nanotoday 2021; 36:101025
[35]	Sun F, Zhu QR, Li TL, Saeed M, Xu ZA, Zhong F, et al. Regulating glucose metabolism with prodrug nanoparticles for promoting photoimmunotherapy of pancreatic cancer. Adv Sci (Weinh) 2021; 8:2002746
[36]	Hou B, Zhou L, Wang H, Saeed M, Wang DG, Xu ZA, et al. Engineering stimuli-activatable boolean logic prodrug nanoparticles for combination cancer immunotherapy. Adv Mater 2020; 32:e1907210
[37]	Adeegbe DO, Liu S, Hattersley MM, Bowden M, Zhou CW, Li S, et al. BET bromodomain inhibition cooperates with PD-1 blockade to facilitate antitumor response in Kras-mutant non-small cell lung cancer. Cancer Immunol Res 2018; 6:1234-1245
[38]	Wang HR, Tang YS, Fang YF, Zhang M, Wang HY, He ZD, et al. Reprogramming tumor immune microenvironment (TIME) and metabolism via biomimetic targeting codelivery of Shikonin/JQ1. Nano Lett 2019; 19:2935-2944
[39]	Kishimoto T, Hagi K, Nitta M, Leucht S, Olfson M, Kane JM, et al. Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia:a meta-analysis of prospective and retrospective cohort studies. Schizophr Bull 2018; 44:603-619
[40]	Kurosky SK, Davis KL, Krishnarajah G. Effect of combination vaccines on completion and compliance of childhood vaccinations in the United States. Hum Vaccin Immunother 2017; 13:2494-2502
[41]	Ku SH, Ryu J, Hong SK, Lee H, Park CB. General functionalization route for cell adhesion on non-wetting surfaces. Biomaterials 2010; 31:2535-2541
[42]	Hong XY, Zhong XF, Du GS, Hou YY, Zhang YT, Zhang ZR, et al. The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency. Sci Adv 2020; 6:eaaz4462. Available from:https://www.science.org/doi/10.1126/sciadv.aaz4462
[43]	Liu YL, Ai KL, Liu JH, Deng M, He YY, Lu LH. Dopamine-melanin colloidal nanospheres:an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy. Adv Mater 2013; 25:1353-1359
[44]	Chen D, Li LL, Tang FQ, Qi S. Facile and scalable synthesis of tailored silica "nanorattle" structures. Adv Mater 2009; 21:3804-3807
[45]	Liu YL, Ai KL, Lu LH. Polydopamine and its derivative materials:synthesis and promising applications in energy, environmental, and biomedical fields. Chem Rev 2014; 114:5057-5115
[46]	Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, et al. Cancer acidity:an ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin Cancer Biol 2017; 43:74-89
[47]	Major M, Law M. Detection of Antibodies to HCV E1E2 by Lectin-Capture ELISA. Methods Mol Biol 2019; 1911:421-432
[48]	Hung BP, Hutton DL, Grayson WL. Mechanical control of tissue-engineered bone. Stem Cell Res Ther 2013; 4:10
[49]	Zou WP, Wolchok JD, Chen LP. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy:mechanisms, response biomarkers, and combinations. Sci Transl Med 2016; 8:328rv4
[50]	Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003; 422:37-44
[51]	Barone A, Hazarika M, Theoret MR, Mishra-Kalyani P, Chen H, He K, et al. FDA approval summary:pembrolizumab for the treatment of patients with unresectable or metastatic melanoma. Clin Cancer Res 2017; 23:5661-5665
[52]	Beaver JA, Theoret MR, Mushti S, He K, Libeg M, Goldberg K, et al. FDA approval of Nivolumab for the first-line treatment of patients with BRAF(V600) wild-type unresectable or metastatic melanoma. Clin Cancer Res 2017; 23:3479-3483
[53]	Francis DM, Manspeaker MP, Schudel A, Sestito LF, O'Melia MJ, Kissick HT, et al. Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy. Sci Transl Med 2020; 12. Available from:https://www.science.org/doi/10.1126/scitranslmed.aay3575
[54]	Francis DM, Thomas SN. Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy. Adv Drug Deliv Rev 2017; 114:33-42
[55]	Thurber GM, Schmidt MM, Wittrup KD. Antibody tumor penetration:transport opposed by systemic and antigen-mediated clearance. Adv Drug Deliv Rev 2008; 60:1421-1434
[56]	Sagiv-Barfi I, Czerwinski DK, Levy S, Alam IS, Mayer AT, Gambhir SS, et al. Eradication of spontaneous malignancy by local immunotherapy. Sci Transl Med 2018; 10. Available from:https://www.science.org/doi/10.1126/scitranslmed.aan4488
[57]	Ingram JR, Blomberg OS, Sockolosky JT, Ali L, Schmidt FI, Pishesha N, et al. Localized CD47 blockade enhances immunotherapy for murine melanoma. Proc Natl Acad Sci U S A 2017; 114:10184-10189

施引文献

资源附件(0)

访问统计

点击查看大图

计量

文章访问数: 52
HTML全文浏览量: 34
PDF下载量: 0
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma

doi: 10.1016/j.apsb.2021.11.020

通讯作者:
Xun Sun,E-mail:sunxun@scu.edu.cn

计量

Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma

计量

目录

留言板

Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma

doi: 10.1016/j.apsb.2021.11.020

通讯作者: Xun Sun,E-mail:sunxun@scu.edu.cn

计量

出版历程

Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma

计量

出版历程

目录

通讯作者:
Xun Sun,E-mail:sunxun@scu.edu.cn